CRH Medical Corp (NYSEAMERICAN:CRHM) was the recipient of a significant decrease in short interest in December. As of December 29th, there was short interest totalling 1,361,862 shares, a decrease of 4.6% from the December 15th total of 1,427,572 shares. Approximately 2.0% of the shares of the company are sold short. Based on an average trading volume of 186,902 shares, the days-to-cover ratio is presently 7.3 days.
CRHM has been the topic of several analyst reports. Zacks Investment Research raised shares of CRH Medical from a “hold” rating to a “buy” rating and set a $3.00 price target on the stock in a research report on Monday, January 8th. Morgan Stanley raised shares of CRH Medical from an “equal weight” rating to an “overweight” rating in a research report on Friday, November 17th. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. CRH Medical has a consensus rating of “Buy” and an average target price of $6.00.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Advisor Group Inc. increased its holdings in shares of CRH Medical by 35.0% in the second quarter. Advisor Group Inc. now owns 36,177 shares of the company’s stock valued at $206,000 after purchasing an additional 9,389 shares during the last quarter. Vanguard Group Inc. acquired a new position in shares of CRH Medical in the second quarter valued at $150,000. PDT Partners LLC increased its holdings in shares of CRH Medical by 176.4% in the second quarter. PDT Partners LLC now owns 50,162 shares of the company’s stock valued at $285,000 after purchasing an additional 32,013 shares during the last quarter. CIBC World Markets Inc. increased its holdings in shares of CRH Medical by 16.4% in the second quarter. CIBC World Markets Inc. now owns 277,406 shares of the company’s stock valued at $1,581,000 after purchasing an additional 39,101 shares during the last quarter. Finally, TD Asset Management Inc. increased its holdings in shares of CRH Medical by 65.3% in the third quarter. TD Asset Management Inc. now owns 111,054 shares of the company’s stock valued at $289,000 after purchasing an additional 43,851 shares during the last quarter.
Shares of CRH Medical (NYSEAMERICAN CRHM) opened at $2.65 on Friday. CRH Medical has a 1 year low of $1.46 and a 1 year high of $9.25. The stock has a market cap of $200.14, a price-to-earnings ratio of 37.86 and a beta of 1.29.
COPYRIGHT VIOLATION WARNING: This story was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://www.dispatchtribunal.com/2018/01/14/crh-medical-corp-crhm-short-interest-down-4-6-in-december.html.
About CRH Medical
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.